Harashima H - Search Results

1

Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery.

Luo J, Tan G, Thong KX, Kafetzis KN, Vallabh N, Sheridan CM, Sato Y, Harashima H, Tagalakis AD, Yu-Wai-Man C. Luo J, et al. Among authors: harashima h. Pharmaceutics. 2022 Nov 16;14(11):2472. doi: 10.3390/pharmaceutics14112472. Pharmaceutics. 2022. PMID: 36432663 Free PMC article.

2

A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.

Moriguchi R, Kogure K, Akita H, Futaki S, Miyagishi M, Taira K, Harashima H. Moriguchi R, et al. Among authors: harashima h. Int J Pharm. 2005 Sep 14;301(1-2):277-85. doi: 10.1016/j.ijpharm.2005.05.021. Int J Pharm. 2005. PMID: 16019173

3

Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.

Khalil IA, Kogure K, Futaki S, Harashima H. Khalil IA, et al. Among authors: harashima h. Int J Pharm. 2008 Apr 16;354(1-2):39-48. doi: 10.1016/j.ijpharm.2007.12.003. Epub 2007 Dec 14. Int J Pharm. 2008. PMID: 18242018 Review.

4

Non-linear pharmacodynamics in the transfection efficiency of a non-viral gene delivery system.

Moriguchi R, Kogure K, Harashima H. Moriguchi R, et al. Among authors: harashima h. Int J Pharm. 2008 Nov 3;363(1-2):192-8. doi: 10.1016/j.ijpharm.2008.07.020. Epub 2008 Jul 30. Int J Pharm. 2008. PMID: 18708133

5

Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.

Fujiwara T, Akita H, Harashima H. Fujiwara T, et al. Among authors: harashima h. Int J Pharm. 2010 Feb 15;386(1-2):122-30. doi: 10.1016/j.ijpharm.2009.11.005. Epub 2009 Nov 13. Int J Pharm. 2010. PMID: 19922779

6

Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cells.

Sato Y, Hatakeyama H, Harashima H. Sato Y, et al. Among authors: harashima h. Biol Pharm Bull. 2010;33(7):1246-9. doi: 10.1248/bpb.33.1246. Biol Pharm Bull. 2010. PMID: 20606322 Free article.

7

Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis.

Kajimoto K, Yamamoto M, Watanabe M, Kigasawa K, Kanamura K, Harashima H, Kogure K. Kajimoto K, et al. Among authors: harashima h. Int J Pharm. 2011 Jan 17;403(1-2):57-65. doi: 10.1016/j.ijpharm.2010.10.021. Epub 2010 Oct 21. Int J Pharm. 2011. PMID: 20970487 Free article.

8

Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.

Sakurai Y, Hatakeyama H, Sato Y, Akita H, Takayama K, Kobayashi S, Futaki S, Harashima H. Sakurai Y, et al. Among authors: harashima h. Biomaterials. 2011 Aug;32(24):5733-42. doi: 10.1016/j.biomaterials.2011.04.047. Epub 2011 May 24. Biomaterials. 2011. PMID: 21605898 Free article.

9

Cell penetrating peptide-mediated systemic siRNA delivery to the liver.

Hayashi Y, Yamauchi J, Khalil IA, Kajimoto K, Akita H, Harashima H. Hayashi Y, et al. Among authors: harashima h. Int J Pharm. 2011 Oct 31;419(1-2):308-13. doi: 10.1016/j.ijpharm.2011.07.038. Epub 2011 Jul 30. Int J Pharm. 2011. PMID: 21827843 Free article.

10

A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.

Sato Y, Hatakeyama H, Sakurai Y, Hyodo M, Akita H, Harashima H. Sato Y, et al. Among authors: harashima h. J Control Release. 2012 Nov 10;163(3):267-76. doi: 10.1016/j.jconrel.2012.09.009. Epub 2012 Sep 20. J Control Release. 2012. PMID: 23000694 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters